OTTAWA (Reuters) - The Federal Court of Canada rejected on Thursday a bid by generic drugmaker Novapharm Ltd to be allowed to market a generic version of Pfizer Inc's erectile dysfunction drug Viagra.
The court said Novapharm should not be allowed to introduce a generic version until Pfizer's Canadian patent expires in 2014. The court rejected Novapharm's allegation that the patent is invalid.
Novapharm is part of Teva Pharmaceutical Industries Ltd
WASHINGTON (Reuters) - Federal Reserve Chairman Ben Bernanke is likely to pass the first hurdle in winning Senate confirmation to serve another term on Thursday but will face unusually strong opposition as his nomination moves ahead.
Marines on the frontlines of the Afghan surge in Helmand Province are ramping up for a battle that their commander says will be the "end of the line" for insurgents. Full Article
In the high-testosterone world of military jets, the words "drone" and "unmanned aerial vehicle" don't fly. Now there's a new term in town. Full Article
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
